JournalArta
Tuesday, November 17, 2026 · JakartaS&P 7,325.08 ▼1.23%USD/IDR 18,258 ▲0.04%
JournalArta
Global Edition
beyond headlines
Advertisement

NHS Recommends Sponge Test for Thousands With Chronic Heartburn

England’s health service could offer a seven-minute capsule-and-sponge test to people with persistent acid reflux. The recommendation is intended to help identify Barrett’s oesophagus, a condition that raises the risk of oesophageal cancer, and guide who needs further testing.

By Elena Vance
November 17, 20262 min read
NHS Recommends Sponge Test for Thousands With Chronic Heartburn
NHS Recommends Sponge Test for Thousands With Chronic Heartburn

England’s National Health Service could offer a seven-minute test to thousands with chronic heartburn condition after health guidance recommended the procedure for people with persistent acid reflux. The capsule-and-sponge test can help identify Barrett’s oesophagus, which raises the risk of oesophageal cancer.

The National Institute for Health and Care Excellence (NICE) recommended two versions, Cytosponge and EndoSign, in draft guidance. A public consultation will run until December 7, with final guidance expected in February 2027.

The test is designed for people with persistent gastro-oesophageal reflux disease, commonly called acid reflux. It could be carried out in GP surgeries, pharmacies and community diagnostic centers in England.

Advertisement

Patients swallow a small capsule attached to a string. The capsule dissolves in the stomach, releasing a small sponge that collects cells from the food pipe as it is pulled back up; laboratories then analyze the cells.

The procedure does not require sedation and is less invasive than an endoscopy, which uses a camera-equipped tube passed down the throat. NICE’s committee found that patients prefer the sponge test to an endoscopy.

Barrett’s oesophagus develops when stomach acid damages the lining of the food pipe and cells change abnormally. NICE’s guidance estimates the condition affects 1 to 2 per cent of adults. Most people with Barrett’s oesophagus do not develop cancer, but the condition increases their risk.

Advertisement

NICE chief executive Professor Jonathan Benger said: “Oesophageal cancer is very difficult to treat when it is diagnosed at a later stage, so identifying people sooner is really important.”

He said capsule sponge tests offer a quick, less invasive way to detect changes linked to cancer or Barrett’s oesophagus, and help identify people who need further testing and treatment. NICE also said patients with a result suggesting Barrett’s oesophagus or cancer would still need an endoscopy to investigate and confirm the findings.

People whose sponge test results are clear should continue to be monitored over the long term, NICE said. NHS England national clinical director for cancer Professor Peter Johnson said thousands had already received the test through pilot programs and that it was “now being considered for rollout across the country.”

Advertisement

If the guidance is confirmed, the NHS will need to begin introducing the technology for eligible patients when it is considered the most suitable option, and provide specialist staff training.

More than 9,000 people are diagnosed with oesophageal cancer in the UK each year. Long-term severe acid reflux and Barrett’s oesophagus can increase the risk, according to the guidance.

Advertisement
Take the quizWhat Kind of Holiday Spender Are You? Take the Black Friday QuizStart →
Advertisement
Most Read
  1. 1U.S. Emergency Alert Test Nov. 17 Is Not a Power Outage
  2. 2Women With Autoimmune Diseases Wait About 4 Years for Diagnosis, Study Finds
  3. 3DUP Chairman Lord Morrow Loses Wife and Daughter Within Hours in NI
  4. 4Micron Stock Falls 28% as $35.16 Billion Buyback Nears
  5. 5I’m A Celebrity 2026 Line-Up: Rooney Leads 11 Stars Into Jungle
Advertisement
Don't Miss

Latest News

All stories →
  1. Markets · StocksJensen Huang Ouster Weakens Challenge to Anthropic’s IPONov 17
  2. Sport · More SportsU.S. Women Take Gold at Worlds With 6-2 Win Over CanadaNov 17
  3. Technology · GadgetsNeurable One Review: Brain-Scanning Headphones Cost $499Nov 17
  4. WorldASEAN Chief Says Haze Talks Went Further, Sea Code Still Has HurdlesNov 17
  5. Advertisement
  6. Markets · StocksMarket Setups: Southern Company and ResMed Rise as Copper WeakensNov 17
  7. Lifestyle · Food & HealthMicroplastics Study Finds Tumor Growth in Cancer-Prone MiceNov 17
  8. Markets · CryptoBitcoin, Ethereum and XRP Face Nvidia Earnings TestNov 17
  9. Markets · Forex & CommoditiesASEAN Oil Reserves: ERIA Models $610 Million in Annual SavingsNov 17